Power Law company profile

Nevro

Biotech & Life Sciences · Redwood City, United States · Founded 2006 · IPO 2014 Unicorn

A global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain

Valuation

$100–500M

Latest valuation · 2026

Unlock exact value

Revenue

$100–500M

Latest reported FY

Unlock exact value

Headcount

500–1k

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

11 investors on Nevro's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 7 investors entered at this stage

Mayo Clinic

Venturi

Bay City Capital

MPM BioImpact

Accuitive Medical Ventures

Aberdare Ventures

Three Arch Partners

Series B+ 4 investors entered at this stage

Johnson & Johnson Development Corporation

Covidien Ventures

NEA

Novo Ventures

Global footprint

Where Nevro has talent and traffic

AI talent share

0.5% of workforce is AI talent
(5 of 917 staff)

Core AI00%

Other AI50.55%

Non-AI workforce91299.45%

Workforce by country

15 countries with
team presence

🇺🇸 United States77.6%

🇨🇷 Costa Rica11.8%

🇩🇪 Germany3.5%

🇬🇧 United Kingdom2.7%

🇦🇺 Australia2.3%

Top 5 of 15 shown

Web traffic by country

18K monthly visits
across markets

🇺🇸 United States72.2%

🇬🇧 United Kingdom8.9%

🇮🇳 India7.8%

🇨🇭 Switzerland4.4%

🇵🇭 Philippines3.3%

Top 5 markets shown

Patent intelligence

$79M patent portfolio · 77 active families

Estimated portfolio value

$79M

43.2% of valuation · 11.8× smaller than top peer Globus Medical ($930M)

77 active patent families

Where Nevro innovates Biomedical engineeringPhysical therapySpinal cordPhysical medicine and rehabilitationElectric signal

Where Nevro concentrates vs peers

Each axis is a top-10 topic across Nevro and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Nevro

An AI-synthesized read of the highest-engagement posts about Nevro on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nevro on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles